Profile
Rich Spano is Vice President of Operations and Quality for FlowCardia, Inc. Prior to joining FlowCardia in April, 2002 he was Quality Manager of Keravision, Inc. from 1995 to 1997.
He held various positions at Advanced Cardiovascular Systems, Inc. from 1988 to 1995 and PercuSurge, Inc. from 1997 to 2002.
Mr. Spano received a Bachelor's degree from San Francisco State University.
Former positions of Rich Spano
Companies | Position | End |
---|---|---|
PercuSurge, Inc.
PercuSurge, Inc. Medical SpecialtiesHealth Technology PercuSurge, Inc. used to develop and market interventional embolic protection devices. It was a medical device company developing a new category of interventional cardiology products that are used in conjunction with the treatment of atherosclerosis or compromised arterial blood flow. It product, GuardWire Plus, was used in conjunction with conventional treatment such as balloon angioplasty and implantable stents, which is the key products used in treating compromised blood flow in the arteries of the human body. It was founded in 1995 and was headquartered in Sunnyvale, CA. | Corporate Officer/Principal | 2001-12-31 |
Keravision, Inc.
Keravision, Inc. Medical SpecialtiesHealth Technology Keravision, Inc. was developed medical products for the treatment of common vision problems. The company was developed a new category of non-laser vision correction products for the treatment of common vision disorders, including myopia, hyperopia and astigmatism, to offer an alternative to eyeglasses, contact lenses and other vision correction surgical procedures. Its first product, Intacs corneal ring segments, based on its proprietary patented technology, has been approved by the FDA for correcting mild myopia. Intacs are the first surgical vision correction technology to be approved by the FDA for distribution and sales that is designed to permanently correct a patient's vision while providing the option of removability. Intacs are composed of two thin half-circles of polymer material that are inserted into the periphery of the cornea to reshape the curvature of the cornea to correct vision. | Corporate Officer/Principal | 1996-12-31 |
Abbott Cardiovascular Systems, Inc.
Abbott Cardiovascular Systems, Inc. Medical SpecialtiesHealth Technology Abbott Cardiovascular Systems, Inc. manufactures medical devices. It also makes cardiac and peripheral vascular repair surgical systems. The company was founded in 1978 and is headquartered in Santa Clara, CA. | Corporate Officer/Principal | 1994-12-31 |
FlowCardia, Inc.
FlowCardia, Inc. Medical SpecialtiesHealth Technology FlowCardia, Inc. designs, develops and manufactures endovascular devices. It offers flowmate Injector to optimize the performance of crosser cto recanalization and crosser catheter, a minimally-invasive endovascular device. The firm also provides portfolio of catheter-based technologies to facilitate guidewire crossing of totally occluded coronary and peripheral arteries. The company was founded by Henry Nita and Erik T. Engelson in 2001 and is headquartered in Sunnyvale, CA. | Chief Operating Officer | - |
Training of Rich Spano
San Francisco State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
FlowCardia, Inc.
FlowCardia, Inc. Medical SpecialtiesHealth Technology FlowCardia, Inc. designs, develops and manufactures endovascular devices. It offers flowmate Injector to optimize the performance of crosser cto recanalization and crosser catheter, a minimally-invasive endovascular device. The firm also provides portfolio of catheter-based technologies to facilitate guidewire crossing of totally occluded coronary and peripheral arteries. The company was founded by Henry Nita and Erik T. Engelson in 2001 and is headquartered in Sunnyvale, CA. | Health Technology |
Keravision, Inc.
Keravision, Inc. Medical SpecialtiesHealth Technology Keravision, Inc. was developed medical products for the treatment of common vision problems. The company was developed a new category of non-laser vision correction products for the treatment of common vision disorders, including myopia, hyperopia and astigmatism, to offer an alternative to eyeglasses, contact lenses and other vision correction surgical procedures. Its first product, Intacs corneal ring segments, based on its proprietary patented technology, has been approved by the FDA for correcting mild myopia. Intacs are the first surgical vision correction technology to be approved by the FDA for distribution and sales that is designed to permanently correct a patient's vision while providing the option of removability. Intacs are composed of two thin half-circles of polymer material that are inserted into the periphery of the cornea to reshape the curvature of the cornea to correct vision. | Health Technology |
Abbott Cardiovascular Systems, Inc.
Abbott Cardiovascular Systems, Inc. Medical SpecialtiesHealth Technology Abbott Cardiovascular Systems, Inc. manufactures medical devices. It also makes cardiac and peripheral vascular repair surgical systems. The company was founded in 1978 and is headquartered in Santa Clara, CA. | Health Technology |
PercuSurge, Inc.
PercuSurge, Inc. Medical SpecialtiesHealth Technology PercuSurge, Inc. used to develop and market interventional embolic protection devices. It was a medical device company developing a new category of interventional cardiology products that are used in conjunction with the treatment of atherosclerosis or compromised arterial blood flow. It product, GuardWire Plus, was used in conjunction with conventional treatment such as balloon angioplasty and implantable stents, which is the key products used in treating compromised blood flow in the arteries of the human body. It was founded in 1995 and was headquartered in Sunnyvale, CA. | Health Technology |
- Stock Market
- Insiders
- Rich Spano